MedPath

河北爱普制药有限公司

Ownership
-
Established
2012-02-15
Employees
-
Market Cap
-
Website
www.aipuzhiyao.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

30

NMPA:30

Drug Approvals

Febuxostat Tablets

Product Name
非布司他片
Approval Number
国药准字H20249299
Approval Date
Nov 5, 2024
NMPA

Febuxostat Tablets

Product Name
非布司他片
Approval Number
国药准字H20249298
Approval Date
Nov 5, 2024
NMPA

Metoprolol Tartrate Tablets

Product Name
酒石酸美托洛尔片
Approval Number
国药准字H20234707
Approval Date
Dec 26, 2023
NMPA

Metoprolol Tartrate Tablets

Product Name
酒石酸美托洛尔片
Approval Number
国药准字H20234706
Approval Date
Dec 26, 2023
NMPA

Ibuprofen Tablets

Product Name
布洛芬片
Approval Number
国药准字H13020447
Approval Date
Oct 18, 2020
NMPA

Chlorphenamine Maleate Tablets

Product Name
马来酸氯苯那敏片
Approval Number
国药准字H13020446
Approval Date
Oct 18, 2020
NMPA

Vitamin C Tablets

Product Name
维生素C片
Approval Number
国药准字H13020435
Approval Date
Oct 18, 2020
NMPA

Erythromycin Ethylsuccinate Granules

Product Name
琥乙红霉素颗粒
Approval Number
国药准字H13020131
Approval Date
Sep 22, 2020
NMPA

Piracetam Tablets

Product Name
吡拉西坦片
Approval Number
国药准字H13022318
Approval Date
Sep 22, 2020
NMPA

Aspirin Enteric-coated Tablets

Product Name
阿司匹林肠溶片
Approval Number
国药准字H13022250
Approval Date
Sep 22, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.